Stockreport

Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL in an oral presentation at ASCO

Autolus Therapeutics plc - American Depositary Shares  (AUTL) 
Last autolus therapeutics plc - american depositary shares earnings: 11/7 07:06 am Check Earnings Report
US:NASDAQ Investor Relations: autolus.com/investor-relations
PDF The majority of patients that responded to obe-cel showed durable responses with the potential for a long-term plateau of survival outcomes40% patients are in ongoing re [Read more]